Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.
Inhalon Biopharma is into developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 26, 2021 | Grant | $7M | 1 | U.S. Army Medical Research & Development Command | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
U.S. Army Medical Research & Development Command | Yes | Grant |